Suppressing TRAP1 sensitizes glioblastoma multiforme cells to temozolomide

Glioma is a common malignant tumor of the central nervous system, accounting for ~50% of intracranial tumors. The current standard therapy for glioma is surgical resection followed by postoperative adjuvant radiotherapy and temozolomide (TMZ) chemotherapy. However, resistance to TMZ is one of the fa...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Nan, Zhu, Peining, Huang, Renxuan, Sun, Liankun, Dong, Delu, Gao, Yufei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438667/
https://www.ncbi.nlm.nih.gov/pubmed/34539842
http://dx.doi.org/10.3892/etm.2021.10681

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438667/
https://www.ncbi.nlm.nih.gov/pubmed/34539842
http://dx.doi.org/10.3892/etm.2021.10681

Ejemplares similares